Peripheral neuropathy during α-interferon therapy in a child with Hodgkin's disease

Pediatric Hematology and Oncology

Volumn 16, Issue 6, 1999, Pages 557-560

  Emir, Suna ^a   Kutluk, Tezer ^a   Chan, Ka Wah ^b   Yalçin, Bilgehan ^a   Varli, Kubilay ^a   Büyükpamukçu, Münevver ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

interferon; Children; Hodgkin's disease; Peripheral neuropathy

Indexed keywords

GAMMA INTERFERON;

ADOLESCENT; ARTICLE; CASE REPORT; DISEASE SEVERITY; DOSE RESPONSE; HODGKIN DISEASE; HUMAN; IMMUNOTHERAPY; LEG; LONG TERM CARE; MALE; NERVE CONDUCTION; NEUROPATHY; ONSET AGE; POLYNEUROPATHY; STEM CELL TRANSPLANTATION; SYMPTOMATOLOGY; TENDON REFLEX;

ADOLESCENT; HODGKIN DISEASE; HUMANS; INTERFERON-ALPHA; MALE; PERIPHERAL NERVOUS SYSTEM DISEASES;

EID: 0032748404     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.1080/088800199276868     Document Type: Article

References (10)

1. Fattovich G, Giustina G, Favarato S, et al. A survey of adverse events in 11241 patients with chronic viral hepatitis treated with alpha interferon. J Hepatol. 1996;24:38-47.
2. Negoro K, Fukusako T, Morimatsu M, et al. Acute axonal polyneuropathy during interferon α-2A therapy for chronic hepatitis type C. Muscle Nerve. 1994;17:1351-1352.
3. Rutkove SB. An unusual axonal polyneuropathy induced by low-dose interferon alpha-2a. Arch Neurol. 1997;54:907-908.
4. Bernsen PLJA, Wong-Chung RE, Janssen JTP. Neuralgic amyotrophy and polyradiculopathy during interferon therapy. Lancet. 1985;5:50.
5. Tambini R, Quattrini A, Fracassetti O, et al. Axonal neuropathy in a patient receiving interferon-alpha therapy for chronic hepatitis C. J Rheumatol. 1997;24:1656-1658.
6. Smedley H, Katrak M, Sikora K, et al. Neurological effects of recombinant human interferon. BMJ. 1983;286:262-264.
7. Klingemann HS, Grigg AP, Wilkie-Boyd K, et al. Treatment with recombinant interferon (α 2b) early after bone marrow transplantation in patients at high risk for relapse. Blood. 1991;78:3306-3311.
8. Mazza P, Tura S, Bocchia M, et al. Alpha-2b recombinant interferon (Intron) in Hodgkin's lymphoma. Eur J Haematol. 1990;52:22-24.
9. Rybak ME, Mc Carroll K, Bernard S, et al. Interferon therapy of relapsed and refractory Hodgkin's disease. J Biol Response Mod. 1990;9:1-4.
10. Csongor K. Interferons in pediatric oncology: end of the beginning or beginning of the end? Med Pediatr Oncol. 1998;30:364-366.